Contact us


Software Industry and Research Combine to Aid Drug Discovery

Dr Julien Michel has collaborated with the software company Cresset under InnovateUK funding to integrate the open source software SOMD developed in his group for the past 7 years into Cresset's fully featured graphical user interface Flare, optimised for use in industry. SOMD is used to carry out Free Energy Perturbation calculations to predict compound activities of drug-like molecules ahead of expensive synthesis and bioactivity assays. 

Sunamp Partnership Highlighted in Scottish Parliament

The School of Chemistry’s partnership with East Lothian-based SME Sunamp Ltd, which has resulted in the first commercialisation of domestic heat storage technology, has been highlighted in the Scottish Parliament’s debate on Scotland as a Science Nation.

Speaking in the debate, Richard Lochead MSP, Minister for Further Education, Higher Education and Science, described the Sunamp collaboration as an example of the great scientific work being carried out in Scotland:

European Young Chemists' Network Representative

Shona Richardson, a 2nd year PhD student in the Campopiano group, has been selected as one of two Royal Society of Chemistry representatives on the European Young Chemists' Network (EYCN).

Her first job will be to present her biocatalysis work at the EYCN 2020 event in Sitges, Spain in January. Over the next two years Shona will build networks with other young chemists from across Europe.

£2.75 million spinout deal offers dialysis hope

Dialysis technology company Invizius has secured funding from a consortium of investors including Mercia Asset Management and the University’s own venture investment fund, Old College Capital.

Invizius stems from years of research by Dr Andy Herbert and his team in the University’s School of Chemistry. In May 2018 he co-founded Invizius and became the Chief Technology Officer at the company.

Reducing risk

The researchers believe they have found a way to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis.

Continued Support for Horrocks Group

The Horrocks Group are once again extremely grateful for a donation made by Dr. Jim Love to support their research into neurodegenerative diseases. His previous gift helped to fund a single-molecule microscope that is currently being used to look at protein "clumps" that are formed in Alzheimer's and Parkinson's diseases. His second gift will be used to continue this important work, and will allow Owen Kantelberg, a second year Ph.D.